Clinical Trials Browser

Phase 3 × Prostatic Neoplasms × Zoledronic Acid × Clear all

NCT00365105 2024-09-20

Zoledronate, Vitamin D, and Calcium With or Without Strontium 89 or Samarium 153 in Preventing or Delaying Bone Problems in Patients With Bone Metastases From Prostate Cancer, Lung Cancer, or Breast Cancer

Phase 3 Completed

261 enrolled 12 charts

BreastGenitourinaryThoracic

Breast Neoplasms, Carcinoma, Non-Small-Cell Lung, Lung Neoplasms, Neoplasm Metastasis, Pain, Prostatic Neoplasms

NCT00058188 2020-12-08

Zolendronate for the Prevention of Bone Loss in Men w/ Prostate CA on Long-Term Androgen Deprivation

Phase 3 Terminated

Osteoporosis, Prostatic Neoplasms

NCT00079001 2020-05-12

Zoledronate in Preventing Skeletal (Bone)-Related Events in Men Who Are Receiving Androgen Deprivation Therapy For Prostate Cancer and Bone Metastases

Phase 3 Completed

645 enrolled 13 charts

Neoplasm Metastasis, Prostatic Neoplasms

NCT00869206 2018-11-07

Zoledronic Acid in Treating Patients With Metastatic Breast Cancer, Metastatic Prostate Cancer, or Multiple Myeloma With Bone Involvement

Phase 3 Completed

1,822 enrolled 19 charts

BreastGenitourinaryPlasma cell

Breast Neoplasms, Multiple Myeloma, Pain, Prostatic Neoplasms

NCT00329797 2017-11-29

Zoledronate in Preventing Osteoporosis and Bone Fractures in Patients With Locally Advanced Nonmetastatic Prostate Cancer Undergoing Radiation Therapy and Hormone Therapy

Phase 3 Completed

109 enrolled 8 charts

Osteoporosis, Prostatic Neoplasms

NCT00193856 2017-10-12

RADAR Trial - Randomised Androgen Deprivation and Radiotherapy

Phase 3 Completed

Prostatic Neoplasms

NCT00375648 2017-06-02

TRAPEZE

Phase 3 Completed

Neoplasms, Pain, Prostatic Neoplasms

NCT00172055 2017-03-06

Study to Assess Efficacy and Safety of Zoledronic Acid and the Value of Markers of Bone Resorption in the Prediction of Bone Metastases and Cancer Treatment-induced Bone Loss (CTIBL) in Patients With Prostate Cancer on Hormone Therapy

Phase 3 Completed

Osteoporosis, Prostatic Neoplasms

NCT00171639 2017-02-23

The Use of Zoledronic Acid in Men on Androgen Deprivation Therapy for Prostate Cancer With Preexisting Osteoporosis

Phase 3 Completed

Prostatic Neoplasms

NCT00685646 2015-10-16

ZAPCA

Phase 3 Completed

Neoplasm Metastasis, Prostatic Neoplasms

NCT00242567 2014-05-07

Study of Zoledronic Acid for Patients With Hormone-sensitive Bone Metastases From Prostate Cancer

Phase 3 Completed

522 enrolled 8 charts

Prostatic Neoplasms

NCT00005073 2013-05-01

Zoledronate Plus Standard Therapy Compared With Placebo Plus Standard Therapy to Prevent Bone Metastases in Patients With Recurrent Prostate Cancer That Has No Symptoms

Phase 3 Terminated

Prostatic Neoplasms

NCT00294437 2012-05-01

ZOMETA® (Zoledronic Acid) for Prevention of Bone Metastases

Phase 3 Terminated

Prostatic Neoplasms

NCT00391950 2009-11-23

Maintaining Bone Strength in Men With Prostate Cancer

Phase 3 Terminated

Prostatic Neoplasms